MARKET

AGRX

AGRX

Agile Therapeutics Inc
OTCMQB
0.324
-0.031
-8.68%
Closed 12:32 06/17 EDT
OPEN
0.355
PREV CLOSE
0.355
HIGH
0.355
LOW
0.315
VOLUME
21.04K
TURNOVER
7.08K
52 WEEK HIGH
12.40
52 WEEK LOW
0.202
MARKET CAP
2.22M
P/E (TTM)
-0.0888
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AGRX last week (0610-0614)?
Weekly Report · 17h ago
Weekly Report: what happened at AGRX last week (0603-0607)?
Weekly Report · 06/10 09:52
Weekly Report: what happened at AGRX last week (0527-0531)?
Weekly Report · 06/03 09:53
Weekly Report: what happened at AGRX last week (0520-0524)?
Weekly Report · 05/27 09:55
Weekly Report: what happened at AGRX last week (0513-0517)?
Weekly Report · 05/20 09:52
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
Agile Therapeutics reported earnings per share of -63 cents for the first quarter of 2024. The company reported revenue of $ million. This was better than the analyst estimate for revenue of $ million. Agile TherAPEutics just reported results.
Investorplace · 05/16 02:54
Agile Therapeutics, Inc. Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2024
Press release · 05/15 22:48
Agile Therapeutics Non-GAAP EPS of -$0.63, revenue of $5.7M
Seeking Alpha · 05/15 20:58
More
About AGRX
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The Company commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.

Webull offers Agile Therapeutics Inc stock information, including OTCMQB: AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGRX stock methods without spending real money on the virtual paper trading platform.